<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Clinical and Molecular Allergy via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Clinical and Molecular Allergy' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Clinical+and+Molecular+Allergy&t=Clinical+and+Molecular+Allergy&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 18 Mar 2010 13:39:11 +0100</lastBuildDate>
        <item>
            <title>Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=3366816&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F8%2F1%2F4</link>
            <description>Conclusions Patients did not show neo-sensitization to tropomyosin, a component of the extract (namely mite group 10) administered. An assessment of a patient's possible pre-existing sensitisation to tropomyosin by skin test and/or specific IgE prior to start mite extract immunotherapy is recommended. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3366816</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3366816</guid>        </item>
        <item>
            <title>Regulation and dysregulation of immunoglobulin E:  a molecular and clinical perspective</title>
            <link>http://www.medworm.com/index.php?rid=3299371&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F8%2F1%2F3</link>
            <description>Conclusion:
Evaluation of a patient with elevated IgE must involve a detailed differential diagnosis and consideration of various immunological and non-immunological disorders. The use of appropriate tests will allow the correct diagnosis to be made. This can often assist in the development of tailored treatments. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3299371</comments>
            <pubDate>Tue, 23 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3299371</guid>        </item>
        <item>
            <title>Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=3276977&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F8%2F1%2F2</link>
            <description>Background:
Subcutaneous Immunotherapy (SCIT) modifies the allergic response and relieves allergic symptoms. SCIT is the only and a very effective treatment for insect venom allergy. We hypothesized that basophil sensitivity, measured through the basophil activation test, would decrease during SCIT up dosing. Expression of CD203c was compared to CD63 as marker for basophil activation, using a Bland Altman plot and ROC curves.
Methods:
Patients (n=18) starting subcutaneous SCIT for wasp allergy with an up dosing scheme of 7 to 11 weeks were enrolled. Heparinised blood samples were drawn at weeks 1-4, 7 and at the first maintenance visit. Basophils were stimulated with 7 log dilutions of V. vespula allergen for 15 min, and were stained with CD203c and CD63. Basophils were identified as CD203...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3276977</comments>
            <pubDate>Tue, 16 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3276977</guid>        </item>
        <item>
            <title>Non-allergic rhinitis: a case report and review</title>
            <link>http://www.medworm.com/index.php?rid=3232594&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F8%2F1%2F1</link>
            <description>Rhinitis is characterized by rhinorrhea, sneezing, nasal congestion, nasal itch and/or postnasal drip. Often the first step in arriving at a diagnosis is to exclude or diagnose sensitivity to inhalant allergens. Non-allergic rhinitis (NAR) comprises multiple distinct conditions that may even co-exist with allergic rhinitis (AR). They may differ in their presentation and treatment. As well, the pathogenesis of NAR is not clearly elucidated and likely varied. There are many conditions that can have similar presentations to NAR or AR, including nasal polyps, anatomical/mechanical factors, autoimmune diseases, metabolic conditions, genetic conditions and immunodeficiency. Here we present a case of a rare condition initially diagnosed and treated as typical allergic rhinitis vs. vasomotor rhini...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3232594</comments>
            <pubDate>Wed, 03 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3232594</guid>        </item>
        <item>
            <title>Oral mite anaphylaxis by Thyreophagus entomophagus in a child: a case report</title>
            <link>http://www.medworm.com/index.php?rid=3023799&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F10</link>
            <description>We present the first case of a child suffering anaphylaxis produced by ingestion of contaminated flour with Thyreophagus entomophagus. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3023799</comments>
            <pubDate>Wed, 25 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3023799</guid>        </item>
        <item>
            <title>Value of eight-amino-acid matches in predicting the allergenicity status of proteins: an empirical bioinformatic investigation</title>
            <link>http://www.medworm.com/index.php?rid=2940586&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F9</link>
            <description>The use of biotechnological techniques to introduce novel proteins into food crops (transgenic or GM crops) has motivated investigation into the properties of proteins that favor their potential to elicit allergic reactions. As part of the allergenicity assessment, bioinformatic approaches are used to compare the amino-acid sequence of candidate proteins with sequences in a database of known allergens to predict potential cross reactivity between novel food proteins and proteins to which people have become sensitized. Two criteria commonly used for these queries are searches over 80-amino-acid stretches for &gt;35% identity, and searches for 8-amino-acid contiguous matches. We investigated the added value provided by the 8-amino-acid criterion over that provided by the &gt;35%-identity-over-80-a...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2940586</comments>
            <pubDate>Thu, 29 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2940586</guid>        </item>
        <item>
            <title>Characterization of Regulatory T cells in Urban Newborns</title>
            <link>http://www.medworm.com/index.php?rid=2581663&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F8</link>
            <description>Conclusions:
U.S. urban newborns have Treg cells that express Foxp3, albeit with an immature phenotype and function as compared to the mothers. Longitudinal follow-up is needed to delineate Treg cell maturation and subsequent risk for atopic diseases in this urban birth cohort. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581663</comments>
            <pubDate>Tue, 07 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581663</guid>        </item>
        <item>
            <title>Genetics of asthma: a molecular biologist perspective</title>
            <link>http://www.medworm.com/index.php?rid=2390591&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F7</link>
            <description>Asthma belongs to the category of classical allergic diseases which generally arise due to IgE mediated hypersensitivity to environmental triggers. Since its prevalence is very high in developed or urbanized societies it is also referred to as &quot;disease of civilizations&quot;. Due to its increased prevalence among related individuals, it was understood quite long back that it is a genetic disorder. Well designed epidemiological studies reinforced these views.The advent of modern biological technology saw further refinements in our understanding of genetics of asthma and led to the realization that asthma is not a disorder with simple Mendelian mode of inheritance but a multifactorial disorder of the airways brought about by complex interaction between genetic and environmental factors. Current a...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2390591</comments>
            <pubDate>Wed, 06 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2390591</guid>        </item>
        <item>
            <title>An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy</title>
            <link>http://www.medworm.com/index.php?rid=2390592&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F6</link>
            <description>Conclusions:
This particular AbM extract may both prevent allergy development and be used as a therapeutical substance against established allergy. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2390592</comments>
            <pubDate>Tue, 05 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2390592</guid>        </item>
        <item>
            <title>T regulatory cells: an overview and intervention techniques to modulate allergy outcome</title>
            <link>http://www.medworm.com/index.php?rid=2262237&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F5</link>
            <description>Dysregulated immune response results in inflammatory symptoms in the respiratory mucosa leading to asthma and allergy in susceptible individuals. The T helper type 2 (Th2) subsets are primarily involved in this disease process. Nevertheless, there is growing evidence in support of T cells with regulatory potential that operates in non-allergic individuals. These regulatory T cells occur naturally are called natural T regulatory cells (nTregs) and express the transcription factor Foxp3. They are selected in the thymus and move to the periphery. The CD4 Th cells in the periphery can be induced to become regulatory T cells and hence called induced or adaptive T regulatory cells. These cells can make IL-10 or TGF-b or both, by which they attain most of their suppressive activity. This review g...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2262237</comments>
            <pubDate>Thu, 12 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2262237</guid>        </item>
        <item>
            <title>Food hypersensitivity by inhalation</title>
            <link>http://www.medworm.com/index.php?rid=2203520&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F4</link>
            <description>Though not widely recognized, food hypersensitivity by inhalation can cause major morbidity in affected individuals. The exposure is usually more obvious and often substantial in occupational environments but frequently occurs in non-occupational settings, such as homes, schools, restaurants, grocery stores, and commercial flights. The exposure can be trivial, as in mere smelling or being in the vicinity of the food. The clinical manifestations can vary from a benign respiratory or cutaneous reaction to a systemic one that can be life-threatening. In addition to strict avoidance, such highly-sensitive subjects should carry self-injectable epinephrine and wear MedicAlert(R) identification. Asthma is a strong predisposing factor and should be well-controlled. It is of great significance that...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2203520</comments>
            <pubDate>Fri, 20 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2203520</guid>        </item>
        <item>
            <title>Mapping IgE-binding epitopes of Cyn d 1, a major allergen from Bermuda Grass Pollen (BGP)</title>
            <link>http://www.medworm.com/index.php?rid=2151933&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F3</link>
            <description>This study describes the localization of the human IgE-binding regions of the major group 1 pollen allergen Cyn d 1 from Bermuda grass.
Methods:
A cDNA library was constructed from Bermuda grass pollen (BGP) using a Lambda gt11 expression vector. The gene encoding the Cyn d 1 allergen was isolated by screening the library with a mouse monoclonal antibody raised against grass group 1 allergen. In order to characterize the IgE epitopes on Cyn d 1, seven overlapping fragments and three deletion mutants were cloned and over-expressed in E. coli. The recombinant fragments and deletion mutants were evaluated for their comparative IgE reactivity with sera of normal and grass pollen allergic patients by ELISA and a dot-blot assay. 
Results:
Analysis of IgE binding regions by overlapping fragments ...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2151933</comments>
            <pubDate>Mon, 02 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2151933</guid>        </item>
        <item>
            <title>Novel concepts in virally induced asthma</title>
            <link>http://www.medworm.com/index.php?rid=2118892&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F2</link>
            <description>Viruses are the predominant infectious cause of asthma exacerbations in the developed world. In addition, recent evidence strongly suggests that viral infections may also have a causal role in the development of childhood asthma. In this article, we will briefly describe the general perception of how the link between infections and asthma has changed over the last century, and then focus on very recent developments that have provided new insights into the contribution of viruses to asthma pathogenesis. Highlighted areas include the contribution of severe early life viral infections to asthma inception, genetic determinants of severe viral infections in infancy, the differences in innate and adaptive immune system cytokine responses to viral infection between asthmatic and nonasthmatic subj...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2118892</comments>
            <pubDate>Tue, 20 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2118892</guid>        </item>
        <item>
            <title>Should digestion assays be used to estimate persistence of potential allergens in tests for safety of novel food proteins?</title>
            <link>http://www.medworm.com/index.php?rid=2106462&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F7%2F1%2F1</link>
            <description>Food allergies affect an estimated 3 to 4% of adults and up to 8% of children in developed western countries. Results from in vitro simulated gastric digestion studies with purified proteins are routinely used to assess the allergenic potential of novel food proteins. The digestion of purified proteins in simulated gastric fluid typically progresses in an exponential fashion allowing persistence to be quantified using pseudo-first-order rate constants or half lives. However, the persistence of purified proteins in simulated gastric fluid is a poor predictor of the allergenic status of food proteins, potentially due to food matrix effects that can be significant in vivo. The evaluation of the persistence of novel proteins in whole, prepared food exposed to simulated gastric fluid may provid...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2106462</comments>
            <pubDate>Thu, 15 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2106462</guid>        </item>
        <item>
            <title>Anaphylaxis to husband's seminal plasma and treatment by local desensitization</title>
            <link>http://www.medworm.com/index.php?rid=2015198&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F13</link>
            <description>We report a case of IgE-mediated anaphylaxis to seminal plasma that was diagnosed by skin prick tests and successfully treated by local desensitization. 32-year-old woman suffering from angioedema and hypotension after exposure to semen was treated with epinephrine upon admission. Skin prick tests and immunoblotting for IgE binding components showed that she was sensitized to her husband's seminal plasma. Local desensitization, which persisted for six months, was achieved by intravaginal administration of serial dilutions of her husband's seminal plasma. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2015198</comments>
            <pubDate>Fri, 05 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2015198</guid>        </item>
        <item>
            <title>Differential response of human basophil activation markers: a multi-parameter flow cytometry approach</title>
            <link>http://www.medworm.com/index.php?rid=1882423&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F12</link>
            <description>Conclusions:
Use of polychromatic flow cytometry allowed efficient basophil electronic purification and identification of different behaviors of the major activation markers. The simultaneous use of two markers of activation and careful choice of activator are essential steps for reliable assessment of human basophil functions. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1882423</comments>
            <pubDate>Thu, 16 Oct 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1882423</guid>        </item>
        <item>
            <title>Diversity of the gut microbiota and eczema in early life</title>
            <link>http://www.medworm.com/index.php?rid=1814291&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F11</link>
            <description>Conclusion:
Our findings suggest that reduced microbial diversity is associated with the development of eczema in early life. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1814291</comments>
            <pubDate>Mon, 22 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1814291</guid>        </item>
        <item>
            <title>CpG Immunotherapy in Chenopodium album sensitized mice: the comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations</title>
            <link>http://www.medworm.com/index.php?rid=1801617&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F10</link>
            <description>Conclusions:
According to the results of this experiment we concluded that immunotherapy via the I.N co-administration of CpG/Ch.a in comparison with S.C route is more effective to stimulate the mucosal and regulatory responses in Ch.a induced asthma. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1801617</comments>
            <pubDate>Wed, 17 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1801617</guid>        </item>
        <item>
            <title>Three dimensional structure directs T-cell epitope dominance associated with allergy</title>
            <link>http://www.medworm.com/index.php?rid=1793219&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F9</link>
            <description>Conclusions:
During the initiation of allergy, the N- and/or C-terminal ends of proteolytic processing intermediates were preferentially loaded into antigen presenting proteins for the priming of CD4+ T cells. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1793219</comments>
            <pubDate>Mon, 15 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1793219</guid>        </item>
        <item>
            <title>The Hoover's sign of pulmonary disease: molecular basis and clinical relevance</title>
            <link>http://www.medworm.com/index.php?rid=1767463&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F8</link>
            <description>We present a clinical and molecular review of the Hoover's sign and explain how it could be utilized in the bedside and emergent management of airway disease. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1767463</comments>
            <pubDate>Fri, 05 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1767463</guid>        </item>
        <item>
            <title>Polymorphisms in IL12A and cockroach allergy in children with asthma</title>
            <link>http://www.medworm.com/index.php?rid=1670207&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F6</link>
            <description>Background:
IL12A has been implicated in T-cell development and may thus influence the development of atopy and allergic diseases. 
Methods:
We tested for association between four linkage disequilibrium
(LD)-tagging SNPs (rs2243123, rs2243151, rs668998, and
rs17826053) in IL12A and asthma and allergy-related (serum total and allergen-specific IgE, and skin test reactivity [STR] to two common allergens) phenotypes in two samples: 417 Costa Rican children with asthma and their parents, and 470 families of 503 white children in the Childhood Asthma Management Program (CAMP). The analysis was conducted using the family-based association test (FBAT) statistic implemented in the PBAT program.
Results:
Among Costa Rican children with asthma, homozygosity for the minor allele of each of two SNPs i...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1670207</comments>
            <pubDate>Thu, 31 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1670207</guid>        </item>
        <item>
            <title>X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=1486052&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F5</link>
            <description>Background:
Common variable immune deficiency (CVID), one of the most common primary immunodeficiency diseases presents in adults, whereas X-linked agammaglobulinemia (XLA), an inherited humoral immunodeficiency, is usually diagnosed early in life after maternal Igs have waned. However, there have been several reports in the world literature in which individuals have either had a delay in onset of symptoms or have been misdiagnosed with CVID and then later found to have mutations in Bruton's tyrosine kinase (BTK) yielding a reclassification as adult-onset variants of XLA. The typical finding of absent B cells should suggest XLA rather than CVID and may be a sensitive test to detect this condition, leading to the more specific test (Btk mutational analysis). Further confirmation may be by m...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1486052</comments>
            <pubDate>Mon, 02 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1486052</guid>        </item>
        <item>
            <title>Severe asthma and the omalizumab option</title>
            <link>http://www.medworm.com/index.php?rid=1452909&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F4</link>
            <description>Atopic diseases and asthma are increasing at a remarkable rate on a global scale. It is now well recognized that asthma is a chronic inflammatory disease of the airways. The inflammatory process in many patients is driven by an immunoglobulin E (IgE)-dependent process. Mast cell activation and release of mediators, in response to allergen and IgE, result in a cascade response, culminating in B lymphocyte, T lymphocyte, eosinophil, fibroblast, smooth muscle cell, and endothelial activation. This complex cellular interaction, release of cytokines, chemokines and growth factors and inflammatory remodeling of the airways leads to chronic asthma. A subset of patients develops severe airway disease which can be extremely morbid and even fatal. While many treatments are available for asthma, it i...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1452909</comments>
            <pubDate>Tue, 20 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1452909</guid>        </item>
        <item>
            <title>Incense smoke: clinical, structural and molecular effects on airway disease</title>
            <link>http://www.medworm.com/index.php?rid=1398378&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F3</link>
            <description>In Asian countries where the Buddhism and Taoism are mainstream religions, incense burning is a daily practice. A typical composition of stick incense consists of 21% (by weight) of herbal and wood powder, 35% of fragrance material, 11% of adhesive powder, and 33% of bamboo stick. Incense smoke (fumes) contains particulate matter (PM), gas products and other organic compounds. On average, incense burning produces particulates greater than 45 mg/g burned (as compared to 10 mg/g burned for cigarettes). The gas products from burning incense include CO, CO2, NO2, SO2, and others. Incense burning also produces volatile organic compounds, such as benzene, toluene, and xylenes, as well as aldehydes and polycyclic aromatic hydrocarbons (PAHs). The air pollution in and around various temples has be...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1398378</comments>
            <pubDate>Fri, 25 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1398378</guid>        </item>
        <item>
            <title>New treatments addressing the pathophysiology of hereditary angioedema</title>
            <link>http://www.medworm.com/index.php?rid=1370209&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F2</link>
            <description>Hereditary angioedema is a serious medical condition caused by a deficiency of C1-inhibitor. The condition is the result of a defect in the gene controlling the synthesis of C1-inhibitor, which regulates the activity of a number of plasma cascade systems. Although the prevalence of hereditary angioedema is low - between 1:10,000 to 1:50,000 - the condition can result in considerable pain, debilitation, reduced quality of life, and even death in those afflicted. Hereditary angioedema presents clinically as cutaneous swelling of the extremities, face, genitals, and trunk, or painful swelling of the gastrointestinal mucosa. Angioedema of the upper airways is extremely serious and has resulted in death by asphyxiation. 
Subnormal levels of C1-inhibitor are associated with the inappropriate act...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1370209</comments>
            <pubDate>Mon, 14 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1370209</guid>        </item>
        <item>
            <title>Usefulness of manufactured tomato extracts in the diagnosis of tomato sensitization: comparison with the prick-prick method</title>
            <link>http://www.medworm.com/index.php?rid=1138672&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F6%2F1%2F1</link>
            <description>The objective of the study was to assess the potential diagnostic of freeze-dried extracts of Canary Islands tomatoes, comparing the wheal sizes induced by prick test with the prick-prick method.
Methods:
Two groups of patients were analyzed: Group I: 26 individuals reporting clinical symptoms induced by tomato contact or ingestion. Group II: 71 control individuals with no symptoms induced by tomato: 12 of them were previously skin prick test positive to a tomato extract, 39 were atopic and 20 were non-atopic. All individuals underwent prick-prick with fresh ripe peel Canary tomatoes and skin prick tested with freeze-dried peel and pulp extracts obtained from peel and pulp of Canary tomatoes at 10 mg/ml. Wheal sizes and prick test positivity (7 mm2) were compared between groups.
Results:
I...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1138672</comments>
            <pubDate>Wed, 09 Jan 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1138672</guid>        </item>
        <item>
            <title>Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kapaB pathway</title>
            <link>http://www.medworm.com/index.php?rid=1050524&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F5%2F1%2F5</link>
            <description>Conclusions:
Our results showed that BAI inhibited the production of inflammatory cytokines through inhibition of NF-kapaB activation and IkapaBalpha phosphorylation and degradation in human mast cells. This inhibitory effect of BAI on the expression of inflammatory cytokines suggests its usefulness in the development of novel anti-inflammatory therapies. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1050524</comments>
            <pubDate>Mon, 26 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1050524</guid>        </item>
        <item>
            <title>Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma</title>
            <link>http://www.medworm.com/index.php?rid=987780&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F5%2F1%2F4</link>
            <description>Conclusion:
Our study indicates that patients with allergic asthma and allergic rhinitis have the same degree of eosinophil inflammation. Despite this, only the asthmatic group experienced an impairment in lung function during the pollen season. This indicated that factors other than the eosinophil inflammation determine whether or not allergic patients develop asthma. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=987780</comments>
            <pubDate>Mon, 29 Oct 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">987780</guid>        </item>
        <item>
            <title>Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics</title>
            <link>http://www.medworm.com/index.php?rid=712209&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F5%2F1%2F3</link>
            <description>While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=712209</comments>
            <pubDate>Wed, 04 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">712209</guid>        </item>
        <item>
            <title>Assessment of allergen cross-reactivity</title>
            <link>http://www.medworm.com/index.php?rid=407912&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F5%2F1%2F2</link>
            <description>The prediction of allergen cross-reactivity is currently largely based on linear sequence data, but will soon include 3D information on homology among surface exposed residues. To evaluate procedures for these predictions, we need ways to quantitatively assess actual cross-reactivity between two allergens. Three parameters are mentioned: 1) the fraction of the epitopes that is cross-reactive; 2) the fraction of IgE that is cross-reactive; 3) the relative affinity of the interaction between IgE and the two allergens. This editorial briefly compares direct binding protocols with the often more appropriate reciprocal inhibition protocols. The latter type of protocol provides information on symmetric versus asymmetric cross-reactivity, and thus on the distinction between complete (=sensitising...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=407912</comments>
            <pubDate>Fri, 09 Feb 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">407912</guid>        </item>
        <item>
            <title>Immune response modulation by curcumin in a latex allergy model</title>
            <link>http://www.medworm.com/index.php?rid=383123&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F5%2F1%2F1</link>
            <description>Conclusions:
These results suggest that curcumin has potential therapeutic value for controlling allergic responses resulting from exposure to allergens. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=383123</comments>
            <pubDate>Thu, 25 Jan 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">383123</guid>        </item>
        <item>
            <title>Mode of delivery and cord blood cytokines: a birth cohort study</title>
            <link>http://www.medworm.com/index.php?rid=207046&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F13</link>
            <description>Conclusion:
Cesarean section is associated with increased levels of IL-13 and IFN-gamma, perhaps because of lack of labor and/or reduced exposure to specific microbes (e.g., gram-positive anaerobes) at birth. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=207046</comments>
            <pubDate>Tue, 26 Sep 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">207046</guid>        </item>
        <item>
            <title>Molecular and immunological characterization of allergens from the entomopathogenic fungus Beauveria bassiana</title>
            <link>http://www.medworm.com/index.php?rid=202504&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F12</link>
            <description>Conclusions:
Four putative Beauveria bassiana allergens were identified. Recombinant proteins corresponding to two of the four, Bb-Eno1 and Bb-Ald were bound by sera IgEs derived from patients with fungal allergies. These data confirm the potential allergenicity of B. bassiana by identification of specific human IgE reactive epitopes. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=202504</comments>
            <pubDate>Fri, 22 Sep 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">202504</guid>        </item>
        <item>
            <title>Specific antibodies to recombinant allergens of Aspergillus fumigatusin cystic fibrosis patients with ABPA</title>
            <link>http://www.medworm.com/index.php?rid=129596&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F11</link>
            <description>Conclusion: When results of several allergens such as Asp f 1, f 2, f 3, f 4, and f 6 in their binding to IgA, IgG, and IgE antibodies were analyzed, a more strong discrimination of CF patients with ABPA was possible from the other groups studied. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=129596</comments>
            <pubDate>Fri, 21 Jul 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">129596</guid>        </item>
        <item>
            <title>Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA)</title>
            <link>http://www.medworm.com/index.php?rid=57790&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F9</link>
            <description>Conclusions:
Comprehensive characterization of genetic variation in extended cytokine candidate gene regions is now needed. Large study networks must follow to investigate the association of risk patterns defined by genetic predisposing and environmental risk factors with specific atopic phenotypes. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=57790</comments>
            <pubDate>Wed, 07 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">57790</guid>        </item>
        <item>
            <title>Intestinal strongyloidiasis and hyperinfection syndrome</title>
            <link>http://www.medworm.com/index.php?rid=44124&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F8</link>
            <description>In spite of recent advances with experiments on animal models, strongyloidiasis, an infection caused by the nematode parasite Strongyloides stercoralis, has still been an elusive disease. Though endemic in some developing countries, strongyloidiasis still poses a threat to the developed world. Due to the peculiar but characteristic features of autoinfection, hyperinfection syndrome involving only pulmonary and gastrointestinal systems, and disseminated infection with involvement of other organs, strongyloidiasis needs special attention by the physician, especially one serving patients in areas endemic for strongyloidiasis. Strongyloidiasis can occur without any symptoms, or as a potentially fatal hyperinfection or disseminated infection. Th2 cell-mediated immunity, humoral immunity and muc...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=44124</comments>
            <pubDate>Tue, 30 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">44124</guid>        </item>
        <item>
            <title>A possible link between sinusitis and lower airway hypersensitivity: the role of Staphylococcal enterotoxin B</title>
            <link>http://www.medworm.com/index.php?rid=93&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F7</link>
            <description>Conclusion:
The present results indicate that a possible link exists between CRS and lower airway hypersensitivity. Sinusitis derived SEB may play a role in sustaining Th2 responses in the low airway hypersensitivity related to sinusitis. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=93</comments>
            <pubDate>Sun, 07 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">93</guid>        </item>
        <item>
            <title>CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper cells from allergic rhinitis patients, asymptomatically sensitized and healthy individuals</title>
            <link>http://www.medworm.com/index.php?rid=94&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F6</link>
            <description>Conclusion:
We conclude that even though allergen and antigen induced increased chemokine receptor expression, no differences in profiles were identified in memory Th cells from patient groups with different atopic status. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=94</comments>
            <pubDate>Wed, 19 Apr 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">94</guid>        </item>
        <item>
            <title>House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=95&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F5</link>
            <description>The objective of this study was to assess whether HDM components of Dermatophagoides pteronissinus with protease activity (Der p 1) and unknown enzymatic activity (Der p 2, Der p 5) induce biological responses in a human airway-derived epithelial cell line (A549), and if so, to elucidate the underlying mechanism(s) of action. A549 cells were incubated with HDM extract, Der p 1, recombinant Der p 2 and recombinant Der p 5. Cell desquamation was assessed by microscopy. The proinflammatory cytokines, IL-6 and IL-8, were measured by ELISA. Intracellular Ca2+ levels were assessed in A549 cells and in mouse fibroblasts expressing the human protease activated receptor (PAR)1, PAR2 or PAR4. HDM extract, Der p 1 and Der p 5 dose-dependently increased the production of IL-6 and IL-8. Added simultane...</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=95</comments>
            <pubDate>Tue, 28 Mar 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">95</guid>        </item>
        <item>
            <title>Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy</title>
            <link>http://www.medworm.com/index.php?rid=96&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F4</link>
            <description>Conclusion:
Vaccination with DNA encoding the major house dust mite allergens provides a promising approach for treating allergic responses to whole house dust mite allergens. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=96</comments>
            <pubDate>Mon, 20 Feb 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">96</guid>        </item>
        <item>
            <title>Impact of IL8 and IL8-Receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections</title>
            <link>http://www.medworm.com/index.php?rid=98&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F2</link>
            <description>Conclusion:
We conclude from our data that IL8 might play a role in the genetic predisposition to asthma and that these effects are different or even opposite to the effects on severe RSV diseases. Furthermore, IL8RA is unlikely to play a major role in the genetics of either disease. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=98</comments>
            <pubDate>Fri, 17 Feb 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">98</guid>        </item>
        <item>
            <title>IL-4 alpha chain receptor (IL-4Rα) polymorphisms in allergic bronchopulmonary sspergillosis</title>
            <link>http://www.medworm.com/index.php?rid=97&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F3</link>
            <description>Conclusion:
The presence of IL-4Rα SNPs, principally ile75val, appears to be a genetic risk for the development of ABPA. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=97</comments>
            <pubDate>Fri, 17 Feb 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">97</guid>        </item>
        <item>
            <title>Aluminum sulfate significantly reduces the skin test response to common allergens in sensitized patients</title>
            <link>http://www.medworm.com/index.php?rid=99&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F4%2F1%2F1</link>
            <description>Conclusion:
Aluminum sulfate was found to reduce the in vivo allergic reaction cascade induced by skin testing with common allergens. The exact mechanism is not clear but appears to involve the alteration of IgE-binding epitopes on the allergen. Our results indicate that it may be possible to diminish the allergenicity of an environment by application of the active agent aluminum sulfate, thus producing environmental control without complete removal of the allergen. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=99</comments>
            <pubDate>Tue, 14 Feb 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">99</guid>        </item>
        <item>
            <title>Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin</title>
            <link>http://www.medworm.com/index.php?rid=100&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F3%2F1%2F16</link>
            <description>A 25-year-old, with type I Diabetes Mellitus with a previous diagnosis of Protamine Allergy but not to human Insulin, started to notice anaphylactic reactions inmmediatly after bolus with Insulin. Skin prick and intradermal test were positive to all insulins. Skin tests to other potential allergens resulted negative. Examination after bolus of Human Insulin revealed urticaria. Daily insulin requirement were around 2-2,4 U/Kg/day. Slow desensitisation with Aspart insulin, the insulin with lowest size of skin test, was performed using subcutaneous insulin pump. Six months after the end of desensitisation his daily insulin requirement decreased to 0.8 U/Kg/day and oral corticosteroids are being reduced with no symptoms. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=100</comments>
            <pubDate>Fri, 23 Dec 2005 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">100</guid>        </item>
        <item>
            <title>Interleukin-4 (IL4) and Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study</title>
            <link>http://www.medworm.com/index.php?rid=101&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F3%2F1%2F15</link>
            <description>Conclusion:
Our results show a trend of association between the genetic combination of the T allele of -33C&gt;TIL4 and the A allele of 576Q&gt;RIL4RA with asthma. This genetic variant was more frequently observed in patients with persistent asthma. As long as this study was performed in a small population, further studies in other populations are needed to confirm these results. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=101</comments>
            <pubDate>Tue, 29 Nov 2005 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">101</guid>        </item>
        <item>
            <title>Severe allergic reactions to guinea pig</title>
            <link>http://www.medworm.com/index.php?rid=102&amp;cid=s_33172_3_f&amp;fid=33172&amp;url=http%3A%2F%2Fwww.clinicalmolecularallergy.com%2Fcontent%2F3%2F1%2F14</link>
            <description>Conclusion:
Severe IgE-mediated reactions can occur following non-occupational guinea pig exposure. Physicians should be aware of this possibility. (Source: Clinical and Molecular Allergy)</description>
            <author>Clinical and Molecular Allergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=102</comments>
            <pubDate>Thu, 27 Oct 2005 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">102</guid>        </item>
    </channel>
</rss>
